Ruxandra Comisel

Ruxandra has five years’ experience in the cell and gene therapy sector and has previously worked on developing sector-specific decisional tools that, amongst others, can help identify cost-effective technologies and determine process performance targets.

In her role, Ruxandra assists the client to identify gaps in their translation journey and support them to find effective solutions. She works closely with the PD Commercialisation Lab by creating cost of goods models to identify cost drivers and help set PD targets.